DePuy Synthes is now Johnson & Johnson MedTech | Orthopaedics. Follow our new page to discover how we’re fueled by innovation at the intersection of biology and technology.
关于我们
DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, offers the world’s most comprehensive portfolio of orthopaedic and medtech solutions to Keep People Moving. By pairing people-centric care and compassion with a strong portfolio of products and data-enabled solutions, DePuy Synthes delivers connected, innovative care. This legacy of innovation is both our heritage and future, rooted in reimagining orthopaedics and strengthened by the expertise and reach of Johnson & Johnson. The content from the DePuy Synthes LinkedIn page is informational only. This content is not a substitute for professional medical advice, diagnosis or treatment. Seek the advice of your physician with questions regarding a medical condition. Reliance on information provided herein is at your own risk. Comments which are off-topic, offensive or promotional are prohibited. Neither DePuy Synthes nor any of its operating companies are responsible for third-party materials appearing on the DePuy Synthes page, including but not limited to linked third-party videos, linked third-party sites and third-party advertisements. DePuy Synthes does not control or endorse this third-party content and makes no representations regarding its accuracy.
- 网站
-
https://www.depuysynthes.com
DePuy Synthes的外部链接
- 所属行业
- 医疗设备
- 规模
- 5,001-10,000 人
- 总部
- Raynham，MA
- 类型
- 上市公司
地点
-
主要
获取路线
325 Paramount Drive
US，MA，Raynham，02767
DePuy Synthes员工
动态
-
#News: We are excited to announce that the VELYS? Robotic-Assisted Solution software V1.8 has launched. https://lnkd.in/gPGaXA8e This software update includes several new clinical features, service care features, and system updates. We are proud to continue to support our cadence of innovation, with more platform-level releases to come!
-
#News: Today, we are excited to announce the launch of the MatrixSTERNUM? Fixation System, a plate and screw fixation system developed to help stabilize and secure the front part of the chest wall after surgeries like coronary artery bypass graft. https://bit.ly/4dJFjC8 Approximately 200,000 people in the U.S. undergo coronary artery bypass graft surgeries every year. With the growing need for better recovery options, this system provides stronger locking strength, faster chest fixation, and thinner, low-profile plates.
-
Ensuring operational efficiency and maintaining top-notch care standards are key priorities for ASC owners and administrators. You can rely on DePuy Synthes to identify and implement efficient solutions, enhancing your daily workflow while you focus on what matters, patients. Learn more about how DePuy Synthes can help you focus on your patients more: https://bit.ly/3JTggiV. #operationalsupport
-
Holly underwent minimally invasive spine surgery with the TELIGEN? System. Hear directly from her and Dr. Sasha Vaziri, a minimally invasive and complex spine neurosurgeon, in this inspiring video: https://bit.ly/4fN3ukC
-
Check out a case report from Ankit Mehta, MD, a neurosurgeon at UI Health, of a minimally invasive two-level VueLIF? using the TELIGEN? System: https://lnkd.in/gt7hjfsi.
-
The TriALTIS? Spine System is DePuy Synthes’ innovation platform for the future. The system delivers improvements in cement augmentation and rod reduction workflows with the aim to improve efficiency in the OR. Click to learn how the TriALTIS Spine System can Elevate Your Experience: https://bit.ly/46LxIPH
-
Your ASC’s capabilities are the blueprint to your success—so ensuring a deep breadth of portfolio offerings, empowered patient care, and a personalized customer focus is how we transform your ASC’s capabilities to achieve what’s possible. With DePuy Synthes, take the next step toward defining the next milestone for your ASC. No matter where you are in your ASC journey, we meet you in the middle to help you imagine the possibilities. https://bit.ly/3UEAdAb #AtTheCenter
-
-
The Enabling Tech Innovation Experience is designed to drive awareness and provide hands-on demonstrations to enhance the participant's understanding of the safe and effective use of Johnson & Johnson MedTech enabling technologies and spine procedural solutions. Register for a stop near you here: https://bit.ly/4fFnNR0
-
-
Dr. Philip Huang discusses some of the latest findings in robotic-assisted total knee arthroplasty (TKA) versus manual. Our VELYS? Robotic-Assisted Solution was associated with fewer follow up visits, reduced readmission rates within the first 90-days post operatively, with overall similar costs of care compared to manual instrumentation. This research brings us a step forward in our goal to #KeepPeopleMoving. To read more about these innovative findings visit this link: https://bit.ly/3YJ2S9k